Neuroprotection by interleukin-6 is mediated by signal transducer and activator of transcription 3 and antioxidative signaling in ischemic stroke

Stroke

Volumn 42, Issue 12, 2011, Pages 3574-3579

  Jung, Joo Eun ^a   Kim, Gab Seok ^a   Chan, Pak H ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cerebral ischemia; IL 6; Mn SOD; Neuroprotection; STAT3

Indexed keywords

ANTIOXIDANT; GLYCOPROTEIN GP 130; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; MANGANESE SUPEROXIDE DISMUTASE; REACTIVE OXYGEN METABOLITE; STAT3 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN ISCHEMIA; CELL DEATH; CYTOKINE RECEPTOR GP130; INTERLEUKIN-6; MALE; MICE; NEURONS; NEUROPROTECTIVE AGENTS; PHOSPHORYLATION; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; STROKE; SUPEROXIDE DISMUTASE;

EID: 84856209632     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.626648     Document Type: Article

References (18)

1. Loddick SA, Turnbull AV, Rothwell NJ. Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. J Cereb Blood Flow Metab. 1998;18:176-179. (Pubitemid 28082514)
2. Ali C, Nicole O, Docagne F, Lesne S, MacKenzie ET, Nouvelot A, et al. Ischemia-induced interleukin-6 as a potential endogenous neuroprotective cytokine against NMDA receptor-mediated excitotoxicity in the brain. J Cereb Blood Flow Metab. 2000;20:956-966. (Pubitemid 30413679)
3. Yamashita T, Sawamoto K, Suzuki S, Suzuki N, Adachi K, Kawase T, et al. Blockade of interleukin-6 signaling aggravates ischemic cerebral damage in mice: possible involvement of Stat3 activation in the protection of neurons. J Neurochem. 2005;94:459-468. (Pubitemid 40995261)
4. Matsuda S, Wen T-C, Morita F, Otsuka H, Igase K, Yoshimura H, et al. Interleukin-6 prevents ischemia-induced learning disability and neuronal and synaptic loss in gerbils. Neurosci Lett. 1996;204:109-112. (Pubitemid 26053684)
5. Suzuki S, Tanaka K, Suzuki N. Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects. J Cereb Blood Flow Metab. 2009;29:464-479.
6. Dugan LL, Ali SS, Shekhtman G, Roberts AJ, Lucero J, Quick KL, et al. IL-6 mediated degeneration of forebrain GABAergic interneurons and cognitive impairment in aged mice through activation of neuronal NADPH oxidase. PLoS One. 2009;4:e5518.
7. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Müller-Newen G, Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J. 2003;374:1-20. (Pubitemid 37046923)
8. Heinrich PC, Behrmann I, Müller-Newen G, Schaper F, Graeve L. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J. 1998;334:297-314. (Pubitemid 28448572)
9. Shyu W-C, Lin S-Z, Chiang M-F, Chen D-C, Su C-Y, Wang H-J, et al. Secretoneurin promotes neuroprotection and neuronal plasticity via the Jak2/Stat3 pathway in murine models of stroke. J Clin Invest. 2008;118:133-148.
10. Dziennis S, Jia T, Rønnekleiv OK, Hurn PD, Alkayed NJ. Role of signal transducer and activator of transcription-3 in estradiol-mediated neuroprotection. J Neurosci. 2007;27:7268-7274. (Pubitemid 47037568)
11. Jung JE, Kim GS, Narasimhan P, Song YS, Chan PH. Regulation of Mn-superoxide dismutase activity and neuroprotection by STAT3 in mice after cerebral ischemia. J Neurosci. 2009;29:7003-7014.
12. Sugawara T, Fujimura M, Morita-Fujimura Y, Kawase M, Chan PH. Mitochondrial release of cytochrome c corresponds to the selective vulnerability of hippocampal CA1 neurons in rats after transient global cerebral ischemia. J Neurosci. 1999;19:RC39:1-6.
13. Chan PH. Mitochondrial dysfunction and oxidative stress as determinants of cell death/survival in stroke. Ann N Y Acad Sci. 2005;1042:203-209. (Pubitemid 40967640)
14. Chan PH. Role of oxidants in ischemic brain damage. Stroke. 1996;27:1124-1129. (Pubitemid 26177617)
15. Stadtman ER, Levine RL. Free radical-mediated oxidation of free amino acids and amino acid residues in proteins. Amino Acids. 2003;25:207-218. (Pubitemid 38043943)
16. Wang P, Powell SR. Decreased sensitivity associated with an altered formulation of a commercially available kit for detection of protein carbonyls. Free Radic Biol Med. 2010;49:119-121.
17. Penkowa M, Hidalgo J. IL-6 deficiency leads to reduced metallothionein-I + II expression and increased oxidative stress in the brain stem after 6-aminonicotinamide treatment. Exp Neurol. 2000;163:72-84. (Pubitemid 30314362)
18. Hernández J, Hidalgo J. Endotoxin and intracerebroventricular injection of IL-1 and IL-6 induce rat brain metallothionein-I and-II. Neurochem Int. 1998;32:369-373. (Pubitemid 28174990)